Case-control Study- Cancer Pain: Uncontrolled Pain as Depression Development Predictor in Oncologic Patients (Fentanyl)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01402830|
Recruitment Status : Completed
First Posted : July 26, 2011
Last Update Posted : February 11, 2013
|Condition or disease||Intervention/treatment|
|Cancer Pain||Other: Visual analogue scales (EVAs)|
|Study Type :||Observational|
|Actual Enrollment :||271 participants|
|Observational Model:||Case Control|
|Official Title:||DPRESS Study. Case-control Study in Cancer Pain: Uncontrolled Pain as Depression Development Predictor in Oncologic Patients|
|Study Start Date :||November 2007|
|Actual Primary Completion Date :||March 2008|
|Actual Study Completion Date :||March 2008|
Visual analogue scales (EVAs) This scale measures the pain intensity.
Other: Visual analogue scales (EVAs)
This scale measures the pain intensity.
- Beck Depression Inventory [ Time Frame: 3 months ]
- Visual scales analog (EVAs) [ Time Frame: 3 months ]
- Number of patients with cancer pain. [ Time Frame: 3 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01402830
|Study Director:||Janssen-Cilag S.A. (formerly Janssen Sp) Clinical Trial||Janssen-Cilag, S.A.|